Figure 2.
Figure 2. Relapse Rate in All patients (A) and AML/MDS (B) based on d56 CD33 chimerism ≥40% vs <40%

Relapse Rate in All patients (A) and AML/MDS (B) based on d56 CD33 chimerism ≥40% vs <40%

Close Modal

or Create an Account

Close Modal
Close Modal